for the treatment of overactive bladder (OAB).This is the first time that CTAF has addressed this topic.

There are many new treatment options for the overactive bladder that are discussed in this article, including the recently introduced drugs tolterodine and oxybutynin XL. Other drugs are in ...

A US district court has said that a key patent held by Astellas on its Myrbetriq drug for urinary incontinence ... agonist therapy used to treat overactive bladder with symptoms of urinary ...

Reducing costs in its healthcare sector is paramount. That’s why, in 2007, the Japanese government began setting targets for generic drugs. At that time, the aim was for 30 percent of all ...

Recently, the media has highlighted a number of instances where, in the absence of competition, the price of an old generic drug has been increased dramatically. Examples include the anti-epilepsy ...

Oct. 9, 2024 — A new study has found some cancers to be slightly more frequent in people with multiple sclerosis (MS) than in people without MS. Types of cancers found to have a small increased ...

It is clearly effective in increasing bladder capacity, but the impacts on bedwetting are less certain with mixed results in research studies. It might be a useful adjunctive therapy to other ...

After hours: November 15 at 7:55 PM EST Loading Chart for DRUG ...

Axsome Therapeutics' Q3 2024 earnings report shows a revenue beat with $104.8m. See why I think selling AXSM stock on any ...

Apr. 30, 2024 — A genetic propensity to higher circulating levels of lipids containing arachidonic acid, an omega-6 polyunsaturated fatty acid found in eggs, poultry, and seafood, has been found ...